Diabetes Deaths In SA Signal Urgent Public Health Emergency

Diabetes Deaths In South Africa reached 27,692 in 2023, raising calls for screening, education and urgent public health action. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...

GLP-1 Drugs In SA Start To Reshape Food And Alcohol Spend

GLP-1 Drugs In SA could spread as cheaper generics and oral pills arrive, changing food and alcohol demand and pushing premium health trends. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...

Obesity as a Chronic Disease: SA Pushes for Treatment Access

Learn how acknowledging obesity as a chronic disease can transform healthcare approaches and reduce long-term health costs. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...

Generic Semaglutide in India: Affordable Treatment Options

Learn how the advent of Generic Semaglutide in India will change the landscape of weight-loss and diabetes medications. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...

Generic Semaglutide Set to Disrupt Global GLP‑1 Market

Aspen Pharmacare is lining up a generic semaglutide launch in Canada, promising big discounts, and widening GLP-1 access. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...